Fundraising Fox

Eikon

Cambridge, US · Founded 2014 · Delaware corporation

Founders & leadership

JT
Jeffrey T. WarmingExecutive
HG
Henry GrodzinsExecutive

Board

PJ
Peter J. RothschildBoard director

Funding

SEC filings, press & company announcements

$1000K disclosed across 1 of 2 rounds · 2017–2025

▶$1000KraisedMay 2017 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter J. RothschildDirector
  • Jeffrey T. WarmingExecutive Officer
  • Henry GrodzinsExecutive Officer, Director
Offering amount
$6M
Amount sold
$1000K
First sale
May 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Eikon Therapeutics to Participate in Investor Conferences in September 2026 | The Manila Timesmanilatimes.net · Aug 2026Merck Veteran-Led Eikon Therapeutics Raises $381 Million in IPO - Bloombergbloomberg.com · Feb 2026Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO | Reutersreuters.com · Feb 2026Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings | BioPharma Divebiopharmadive.com · Feb 2026Eikon Therapeutics Raises $350 Million in Series D Funding to Advance Oncology Pipeline | PharmExecpharmexec.com · Jan 2026Eikon remains in megaround mode with $350M series D to fund cancer trialsfiercebiotech.com · Feb 2025

Frequently asked questions

How much funding has Eikon raised?
Eikon has disclosed $1000K raised across 1 of its 2 known rounds.
Where is Eikon headquartered?
Eikon is headquartered in Cambridge, US.